Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA-seq of Tipranavir-treated primary tumor-derived human gastric cancer stem cells (GCSCs)

ABSTRACT: We performed RNA-seq analysis of human gastric cancer stem cell treated with or without Tipranavir to elucidate the effect of Tipranavir on GCSCs, and find Tipranavir's potential targets in GCSCs.

ORGANISM(S): Homo sapiens

PROVIDER: GSE161825 | GEO | 2021/07/31

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

RNA-seq of primary tumor-derived human gastric cancer stem cells (GCSCs) and differentiated cells (GCSCs treated with serum)

Project description:We performed RNA-seq analysis of human gastric cancer stem cell treated with or without serum to analyze the differentially expressed genes between GCSCs and differentiated cells, and find the potential key factors in GCSCs.

2023-03-01 | GSE210249 | GEO

Whole transcriptome sequencing of gastric cancer stem cells and non-gastric cancer stem cells

Project description:As a subpopulation of tumor cells with stemness characteristics such as self-renewal ability and high oncogenicity, gastric cancer stem cells (GCSCs) are considered to be tumor-initiating cells and are the root cause of cancer recurrence and chemoresistance. Therefore, an in-depth study of the stemness characteristics and maintenance mechanism of GCSCs is of great significance for the treatment of gastric cancer (GC). In this study, GCSCs and non-gastric cancer stem cells (Non-GCSCs) derived from tumor tissues of GC patients were used for whole transcriptome sequencing. The goal of identifying key differentially expressed circRNAs, lncRNAs, miRNAs and mRNAs associated with GCSCs. In conclusion, we mapped the molecular feathers at RNA level closely related to GCSCs and revealed certain ncRNAs with great research potentia based on the whole transcriptome sequencing.

2025-11-14 | GSE274738 | GEO

RNA-seq of Tipranavir-treated primary tumor-derived human gastric cancer stem cells (GCSCs)

Project description:RNA-seq of Tipranavir-treated primary tumor-derived human gastric cancer stem cells (GCSCs)

| PRJNA679578 | ENA

RNA-seq of primary tumor-derived human gastric cancer stem cells (GCSCs) and differentiated cells (GCSCs treated with serum)

Project description:RNA-seq of primary tumor-derived human gastric cancer stem cells (GCSCs) and differentiated cells (GCSCs treated with serum)

| PRJNA864830 | ENA

KDM4C epigenetically regulates and forms a feed-forward loop with ALDH1A3 to maintain gastric cancer stemness

Project description:Gastric cancer (GC) stem cells (GCSCs) are characterized as high level of ALDH activity, however, the mechanisms of maintenance of high ALDH activity and stemness in GCSCs are largely unknown. Here, we report that KDM4C, a H3K9me2/3-demethylase, epigenetically regulates ALDH1A3 by histone demethylation and forms a feed-forward loop with ALDH1A3 to supports GS stemness. Ectopic expression of both KDM4C and ALDH1A3 promotes the properties of GCSCs, including spherogenecity, self-renewal, CD44 expression and ALDH activity; knockdown of anyone abolished the effect of each other. KDM4C directly binds to the promoter of ALDH1A3, leads to histone demethylation, thereby promoting ALDH1A3 transcription. Upregulated ALDH1A3 in turn transcriptionally upregulates KDM4C. Simultaneous inhibition of KDM4C and ALDH1A3 synergistically sensitizes GC sphere-derived cells to traditional chemotherapeutic drugs. The finding that upregulated ALDH1A3 promotes its own transcription via KDM4C-mediated epigenetic modification represents an important feed-forward mechanism for GCSCs to maintain stemness and promote tumourigenesis and our work thus suggests a novel therapeutic strategy for eradicating human GCSCs. To investigate the mechanisms underlying KDM4C promoting CG stemness, we identified the differentially expressed proteins (DEPs) between KDM4C-overexpressing and control AGS cells by iTRAQ-based quantitative proteomic analysis.

2022-02-16 | PXD023455 | Pride

Array CGH analysis of 56 primary gastric cancers for elucidating prognostic biomarkers

Project description:Array CGH analysis was done with 56 primary gastric cancers to elucidate prognostic biomarkers on the BAC basis. Using the extracted genomic DNA from 56 primary gastric cancers, array CGH was done to elucidate the prognostic biomarkers.

2010-08-10 | E-GEOD-15436 | biostudies-arrayexpress

Expression data from mouse gastric tumor models

2009-07-02 | GSE16902 | GEO

Expression data from mouse gastric tumor models

Project description:Transgenic mice with prostaglandin E2 pathway in stomach develops gastric tumors. Simultaneous activation of both Wnt pathway and prostaglandin E2 pathway causes gastric adenocarcinoma. Combination of prostaglandin E2 pathway activation and suppression of BMP pathway leads to the development of gastric hamartomas. We used microarrays to find the mechanism of these tumor development and to evaluate whether these mouse models recapitulate human gastric tumors. Glandular stomach from three C57BL/6 wild-type, five K19-Wnt1 transgenic, three K19-C2mE, five K19-Wnt1/C2mE, two K19-Nog, and three K19-Nog/C2mE transgenic mice were used. All mice were female at 18-65 weeks of age.

2009-07-02 | E-GEOD-16902 | biostudies-arrayexpress

Array CGH analysis of 56 primary gastric cancers for elucidating prognostic biomarkers

Project description:Array CGH analysis was done with 56 primary gastric cancers to elucidate prognostic biomarkers on the BAC basis.

2010-08-10 | GSE15436 | GEO

Expression profiling of frozen primary and patient derived xenograft gastric cancer

Project description:Expression profiling of frozen primary and patient derived xenograft gastric cancer

2019-10-15 | GSE98708 | GEO